SMAD3 and osteosarcoma: This study firstly investigated that miR-16-5p inhibited the proliferation, migration, and invasion of osteosarcoma via suppressing the expression of Smad3, meaning that miR-16-5p may be regarded as a potential target in the treatment of osteosarcoma.